IN-DATE
383594: BD Nexiva Diffusics Closed IV Catheter for Power Injection 18G x 1.25"
Sign in to add this product to your favorites!
| Price: | $2.85 EACH |
|---|---|
| Quantity: | |
| In Stock: | 68 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 1 hours 51 minutes and choose overnight shipping at checkout. |
Additional Details
BD Nexiva Diffusics Closed IV Catheter for Power Injection
The unique diffusion tip of BD Nexiva Diffusics™ Closed IV Catheter System adds three laser-cut teardrop holes around the catheter tip. It can accommodate power injection up to 325 psi and meet high flow injection protocols
The BD Nexiva Diffusics™ Catheter System is built on the Nexiva platform and is specifically designed to address the infusion challenges of contrast-enhanced CT.
AccessGUDID Info
- FDA Product Code: FOZ
- FDA Product Code Name: Catheter,intravascular,therapeutic,short-term less than 30 days
- GMDN Term Code: 64574
- GMDN Term Name: Peripheral intravenous cannula
- GMDN Term Description: A short, thin tube intended to be inserted into a peripheral vein (typically on the hand/arm) to enable short-term (< 30 days) intravenous (IV) access for administration of fluids/medication and blood sampling. Also referred to as a peripheral IV catheter, it is typically assembled with a dedicated introduction needle, and usually includes connectors, injection ports, and wings for fixation. It is not intended to be advanced to the central vasculature. This is a single-use device.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
